Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Minimal inhibitory concentrations of linezolid against clinical isolates of coryneform bacteria.

Literature DB >> 16175358

Minimal inhibitory concentrations of linezolid against clinical isolates of coryneform bacteria.

Abstract

In order to evaluate the efficacy of linezolid for treating severe infections with coryneform bacteria, the activity of linezolid was tested in vitro against 425 clinically relevant isolates of coryneform bacteria and compared with the activity of penicillin and erythromycin. The minimal inhibitory concentration of linezolid did not exceed 2 microg/ml for any of the isolates tested, indicating that this agent has very good activity against coryneform bacteria. These results suggest linezolid is a possible alternative antimicrobial agent for the treatment of severe infections caused by coryneform bacteria.

Entities: Chemical Disease

Mesh：

Substances：

Year: 2005 PMID： 16175358 DOI： 10.1007/s10096-005-0014-x

Source DB: PubMed Journal: Eur J Clin Microbiol Infect Dis ISSN： 0934-9723 Impact factor: 3.267

11 in total

1. In vitro evaluation of AZD2563, a new oxazolidinone, tested against unusual gram-positive species.

Authors: Ronald N Jones; Douglas J Biedenbach; Tamara R Anderegg
Journal: Diagn Microbiol Infect Dis Date: 2002-02 Impact factor: 2.803

2. AZD2563, a novel oxazolidinone: definition of antibacterial spectrum, assessment of bactericidal potential and the impact of miscellaneous factors on activity in vitro.

Authors: A Wookey; P J Turner; J M Greenhalgh; M Eastwood; J Clarke; C Sefton
Journal: Clin Microbiol Infect Date: 2004-03 Impact factor: 8.067

Review 3. Clinical microbiology of coryneform bacteria.

Authors: G Funke; A von Graevenitz; J E Clarridge; K A Bernard
Journal: Clin Microbiol Rev Date: 1997-01 Impact factor: 26.132

4. Antimicrobial susceptibility patterns of some recently established coryneform bacteria.

Authors: G Funke; V Pünter; A von Graevenitz
Journal: Antimicrob Agents Chemother Date: 1996-12 Impact factor: 5.191

5. Activity of the oxazolidinones AZD2563 and linezolid against Corynebacterium jeikeium and other Corynebacterium spp.

Authors: A P Johnson; M Warner; H Malnick; D M Livermore
Journal: J Antimicrob Chemother Date: 2003-03 Impact factor: 5.790

Review 6. A review of linezolid: the first oxazolidinone antibiotic.

Authors: Dennis L Stevens; Brian Dotter; Karl Madaras-Kelly
Journal: Expert Rev Anti Infect Ther Date: 2004-02 Impact factor: 5.091

7. In vitro activities of U-100592 and U-100766, novel oxazolidinone antibacterial agents.

Authors: G E Zurenko; B H Yagi; R D Schaadt; J W Allison; J O Kilburn; S E Glickman; D K Hutchinson; M R Barbachyn; S J Brickner
Journal: Antimicrob Agents Chemother Date: 1996-04 Impact factor: 5.191

8. In vitro antimicrobial activities and spectra of U-100592 and U-100766, two novel fluorinated oxazolidinones.

Authors: R N Jones; D M Johnson; M E Erwin
Journal: Antimicrob Agents Chemother Date: 1996-03 Impact factor: 5.191

9. In vitro activities of daptomycin, vancomycin, quinupristin- dalfopristin, linezolid, and five other antimicrobials against 307 gram-positive anaerobic and 31 Corynebacterium clinical isolates.

Authors: Ellie J C Goldstein; Diane M Citron; C Vreni Merriam; Yumi A Warren; Kerrin L Tyrrell; Helen T Fernandez
Journal: Antimicrob Agents Chemother Date: 2003-01 Impact factor: 5.191

3. Comprehensive study of Corynebacterium freneyi strains and extended and emended description of Corynebacterium freneyi Renaud, Aubel, Riegel, Meugnier, and Bollet 2001.

Authors: Guido Funke; Reinhard Frodl
Journal: J Clin Microbiol Date: 2007-12-12 Impact factor: 5.948

4. Clinical update on linezolid in the treatment of Gram-positive bacterial infections.

Authors: Sally Ager; Kate Gould
Journal: Infect Drug Resist Date: 2012-06-25 Impact factor: 4.003

4 in total